AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Altana receives US approval for intravenous form of gastrointestinal drug.(Protonix is proton pump inhibitor)(Brief Article)

M2 Europharma

| March 26, 2001 | COPYRIGHT 2002 M2 Communications Ltd. (Hide copyright information)Copyright

M2 EUROPHARMA-(C)1999-2001 M2 COMMUNICATIONS LTD

The German pharmaceutical company Altana AG has received approval from the US Food and Drug Administration to market an intravenous (IV) form of its Protonix gastrointestinal drug in the US.

The IV version, which is already available in 43 countries worldwide, is meant for patients who are unable to take Protonix - known as Pantoprazole in the US - in tablet form. According to Altana the approval makes Protonix/Pantoprazole the first …

Related articles from newspapers, magazines, journals, and more
PRESS RELEASE: Protonix IV (pantoprazole sodium) for injection-the first and...
News wire article from: Chemical Business Newsbase May 23, 2001 700+ words
Early detection and innovative treatments to help boost gastrointestinal drug...
News wire article from: Chemical Business Newsbase July 25, 2006 700+ words
Generic onslaught could permanently alter PPI market.
News wire article from: Asia Africa Intelligence Wire August 18, 2003 700+ words
AGI Therapeutics plc - License Agreement.
News wire article from: Europe Intelligence Wire September 27, 2006 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily